
Sign up to save your podcasts
Or


Studies are showing that the first dose of Pfizer-BioNTech vaccine is highly effective, helping boost B-C's confidence to delay the second dose of all approved COVID-19 vaccines to four months. Canada's National Advisory Committee on Immunization also says Pfizer, Moderna, and AstraZeneca - can now be considerably extended, while still being effective. U-B-C adjunct infectious diseases professor Dr. Horacio Bach provides his thoughts and predicts what COVID vaccine programs may look like in the future.
By Jeff AndreasStudies are showing that the first dose of Pfizer-BioNTech vaccine is highly effective, helping boost B-C's confidence to delay the second dose of all approved COVID-19 vaccines to four months. Canada's National Advisory Committee on Immunization also says Pfizer, Moderna, and AstraZeneca - can now be considerably extended, while still being effective. U-B-C adjunct infectious diseases professor Dr. Horacio Bach provides his thoughts and predicts what COVID vaccine programs may look like in the future.